Tokyo Tape
Sign in
← CareNet

Quarterly report · Q1

2150.TEDINET S100QR5M
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.5bn2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥9.3bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥2.2bn2022-01-01 → 2022-03-31Cons.Net sales
Operating income¥715m2023-01-01 → 2023-03-31Cons.Operating income
Operating income¥838m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income¥716m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥2.9bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥839m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥716m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥839m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥458m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥558m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥464m2023-01-01 → 2023-03-31Cons.Profit loss
Net income¥564m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥12.4bnat 2023-03-31Cons.Assets
Total assets¥13.1bnat 2022-12-31Cons.Assets
Total assets¥10.1bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.2bnat 2023-03-31Cons.Liabilities
Total liabilities¥3.1bnat 2022-12-31Cons.Liabilities
Net assets / equity¥10.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥8.4bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥7.8bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥7.8bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥10.272023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.72022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.612022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥336m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥985m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥66m
—segment totalrevenue2023-01-01 → 2023-03-31¥2.5bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥2.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥308m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥2.0bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥2.0bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥1.1bn
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥207m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥207m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥88m
—segment totalrevenue2022-01-01 → 2022-03-31¥2.2bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥2.2bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 327
ItemContextValueUnit
Net defined benefit liabilityCurrentQuarterInstant10616000JPY
Asset retirement obligations nclPrior1YearInstant50128000JPY
Asset retirement obligations nclCurrentQuarterInstant50140000JPY
Reserve for officer stock benefitsPrior1YearInstant37926000JPY
Reserve for officer stock benefitsCurrentQuarterInstant43344000JPY
Reserve for employee stock benefitsPrior1YearInstant11020000JPY
Reserve for employee stock benefitsCurrentQuarterInstant11020000JPY
Provision for directors retirement benefitsPrior1YearInstant5250000JPY
Provision for directors retirement benefitsCurrentQuarterInstant6375000JPY
Other nclPrior1YearInstant9705000JPY
Other nclCurrentQuarterInstant11441000JPY
Noncurrent liabilitiesPrior1YearInstant229023000JPY
Noncurrent liabilitiesCurrentQuarterInstant229837000JPY
LiabilitiesPrior1YearInstant3051353000JPY
LiabilitiesCurrentQuarterInstant2181768000JPY
Capital stockPrior1YearInstant2405636000JPY
Capital stockCurrentQuarterInstant2405636000JPY
Capital surplusPrior1YearInstant3072443000JPY
Capital surplusCurrentQuarterInstant3072443000JPY
Retained earningsPrior1YearInstant5245727000JPY
Retained earningsCurrentQuarterInstant5433730000JPY
Treasury stockPrior1YearInstant-700753000JPY
Treasury stockCurrentQuarterInstant-700753000JPY
Shareholders equityPrior1YearInstant10023053000JPY
Shareholders equityCurrentQuarterInstant10211056000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-35904000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-47092000JPY
Valuation and translation adjustmentsPrior1YearInstant-35904000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-47092000JPY
Subscription rights to sharesPrior1YearInstant0JPY
Subscription rights to sharesCurrentQuarterInstant0JPY
Non controlling interestsPrior1YearInstant32894000JPY
Non controlling interestsCurrentQuarterInstant39283000JPY
Net assetsPrior1YearInstant10020043000JPY
Net assetsCurrentQuarterInstant10203248000JPY
Liabilities and net assetsPrior1YearInstant13071397000JPY
Liabilities and net assetsCurrentQuarterInstant12385016000JPY
Net salesPrior1YTDDuration2222788000JPY
Net salesCurrentYTDDuration2526715000JPY
Cost of salesPrior1YTDDuration711974000JPY
Cost of salesCurrentYTDDuration934253000JPY
Gross profitPrior1YTDDuration1510814000JPY
Gross profitCurrentYTDDuration1592461000JPY
Selling general and administrative expensesPrior1YTDDuration672780000JPY
Selling general and administrative expensesCurrentYTDDuration877401000JPY
Operating incomePrior1YTDDuration838033000JPY
Operating incomeCurrentYTDDuration715060000JPY
Interest income noiPrior1YTDDuration84000JPY
Interest income noiCurrentYTDDuration588000JPY
Foreign exchange gains noiPrior1YTDDuration5643000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass